Treatment of secondary hyperparathyroidism: calcimimetics, selective activators of vitamin D receptor (VDRAs) or combination therapy?
DOI:
https://doi.org/10.33393/gcnd.2007.1518Abstract
No abstractDownloads
Download data is not yet available.
Downloads
Published
2007-07-01
How to Cite
Cozzolino, M., Pasho, S., Crovetto, C., & Missaglia, E. (2007). Treatment of secondary hyperparathyroidism: calcimimetics, selective activators of vitamin D receptor (VDRAs) or combination therapy?. Giornale Di Clinica Nefrologica E Dialisi, 19(3-4), 28–33. https://doi.org/10.33393/gcnd.2007.1518
Issue
Section
Original articles